| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19cc3a6838d13ce48b7131f085b981ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be3d0d183be8e4f536a4ced63292fd8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3052104fbdbc9b665ff4f1c18fb42df8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f574183b09b25f47ca660d48b46cdc9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-66 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2008-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b351f15bf547d1298de152ad95e9c64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f311e3972c58f0791286eb984eca3bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62e33232c41af86021e60e6d86e6a032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f01956f37ac131ee14969e3314e430d1 |
| publicationDate |
2010-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010035810-A1 |
| titleOfInvention |
Adiponectin production enhancer |
| abstract |
The present invention relates to an adiponectin production enhancer comprising sericin as an active ingredient, and to a pharmaceutical composition and food and drink comprising sericin. These are effective in the prevention and/or amelioration of various diseases caused by reduction of blood adiponectin level such as arteriosclerosis, fatty liver and diabetes associated with obesity. The enhancer, the pharmaceutical composition and the food and drink according to the invention have excellent adiponectin production enhancing effects as well as high safety and are expected to be broadly applied to a variety of pharmaceutical preparations and food and drink. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020141778-A1 |
| priorityDate |
2007-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |